WHO Publishes Profiles for Long-Acting TB Injectable Treatments

The World Health Organization (WHO) has released new target regimen profiles for long-acting injectable treatments for tuberculosis (TB) prevention and therapy. This initiative aims to improve treatment adherence by shifting the burden from patients to healthcare systems, potentially leading to better outcomes in the global fight against TB.